Yibin Deng

Title: Yibin Deng: Innovator in Anti-Tumor Drug Development

Introduction

Yibin Deng is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor drugs. His innovative work focuses on creating effective treatment options for cancer patients.

Latest Patents

Yibin Deng holds a patent for an "Anti-tumor platinum-based drug mineralized protein nanoparticle, preparation method therefor and use thereof." This patent describes a novel formulation that includes a platinum drug and a protein. The proteins used in this formulation are selected from a group that includes albumin, transferrin, hemoglobin, and low-density lipoprotein. The platinum drugs involved in this innovation include cisplatin, iodoplatin, bromoplatin, oxaliplatin, carboplatin, or nedaplatin. The drug loading of these nanoparticles ranges from 1% to 50%, showcasing a versatile approach to drug delivery.

Career Highlights

Yibin Deng is affiliated with Soochow University, where he continues to advance his research in drug development. His work has garnered attention for its potential to improve cancer treatment outcomes. With a focus on innovative solutions, he has established himself as a key figure in the pharmaceutical research community.

Collaborations

Yibin Deng collaborates with notable colleagues such as Huabing Chen and Hong Yang. Their combined expertise contributes to the advancement of research in the field of anti-tumor therapies.

Conclusion

Yibin Deng's contributions to the development of anti-tumor drugs highlight his commitment to improving cancer treatment. His innovative approach and collaboration with esteemed colleagues position him as a significant inventor in the pharmaceutical industry.